Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
44.65
+0.55 (1.25%)
At close: Feb 6, 2026, 4:00 PM EST
44.65
0.00 (0.00%)
Pre-market: Feb 9, 2026, 4:04 AM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $25.77 billion as of February 9, 2026. Its market cap has increased by 89.45% in one year.
Market Cap
25.77B
Enterprise Value
33.78B
1-Year Change
89.45%
Ranking
Category
Stock Price
$44.65
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $25.77B, an increase of 63.53%. That is a compound annual growth rate of 9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 19.08B | 15.55% |
| Dec 31, 2025 | 16.51B | 45.66% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 43.35B |
| BeOne Medicines AG | 39.16B |
| Insmed | 31.96B |
| BioNTech SE | 26.75B |
| Incyte | 21.28B |
| Genmab | 19.08B |
| Revolution Medicines | 18.85B |
| Roivant Sciences | 18.48B |